The Latest Cardiac and Vascular News
SANTA CLARA, CA, April 11, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of Neovasc Inc. (“Neovasc”). The Neovasc Reducer System (the “Reducer”) […]
Expand Partnerships and Clinical Deployments ST. LOUIS, April 11, 2023 /PRNewswire/ — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, has closed an $8.5 million Series B financing. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, including TechWald Holding, […]
In Conjunction with His Appointment, Mr. Wambeke Purchased $750,000 of Common Shares from DiaMedica in a Private Placement Priced Above Market MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing a novel treatment for acute ischemic stroke (AIS), today announced the appointment of David Wambeke, as […]
30-year medical device veteran to lead AVS’ operational direction after long tenure with Boston Scientific BOSTON–(BUSINESS WIRE)–AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Sean Gilligan as the company’s new Chief Operating Officer. He […]
PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, including ischemic stroke, today discloses the total number of voting rights and shares as of March 31, 2023 (pursuant to Article L. 233-8 II of […]
Financing will further drive commercial scale for HeartFlow’s AI-enabled portfolio of precision heart care products MOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million Series F funding round by its parent company HeartFlow […]
IRVINE, Calif., April 05, 2023 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that it has appointed Ken MacLeod, Ph.D., life sciences and medical device industry veteran, to its Board of Directors. Dr. MacLeod has over 35 years of […]
SCHAFFHAUSEN, CH / ACCESSWIRE / April 5, 2023 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, receives subscription commitment subject to certain conditions, of bonds to an aggregated amount of EUR 40 million. Bonds amounting to EUR 20 […]
BioStar Capital led the round with CUE Growth Partners BOSTON, April 4, 2023 – AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it closed an additional $8.8 million in new financing, bringing its Series B […]
Cardiovascular Imaging Expert to Lead Core Lab Services in Support of Clinical Trials BOSTON, April 3, 2023 /PRNewswire/ — As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.Dr. Dai is a […]
